Literature DB >> 1333033

An immunohistochemical study of the blood vessels within primary hepatocellular tumours.

A P Dhillon1, R Colombari, K Savage, P J Scheuer.   

Abstract

We studied the blood vessels in routinely formalin-fixed and paraffin-processed tissue from 18 hepatocellular carcinomas, three "small" hepatocellular carcinomas, and 15 benign nodular lesions representing a spectrum of conditions with which liver cell carcinomas may be confused. These were stained for a basement membrane component (collagen IV) and endothelial markers (Factor VIII-related antigen, Ulex europaeus lectin binding, and QBEnd10). The staining pattern of normal and cirrhotic liver was also examined in tissue removed with these tumours. There was an increased expression by small blood vessels for collagen IV in carcinomas and benign lesions compared with cirrhotic nodules. All endothelial markers (Factor VIII-related antigen, QBEnd10, and Ulex europaeus binding) were best expressed in liver cell carcinomas. These differences were of degree and pattern, and no single marker distinguished benign from malignant lesions. The differences in staining pattern taken together with other clinical and pathological information should be useful in diagnosis particularly of small liver cell carcinoma. The differences between benign and malignant lesions support the idea that malignant neoplastic blood vessels in the liver are of a different basic biological type from normal hepatic sinusoids, and this difference could be exploited further in future therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333033     DOI: 10.1111/j.1600-0676.1992.tb00579.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  8 in total

1.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

2.  Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.

Authors:  A Quaglia; M A Jutand; A Dhillon; A Godfrey; R Togni; P Bioulac-Sage; C Balabaud; M Winnock; A P Dhillon
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 3.  Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Martine Soell; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mosaad Megahed
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Liver cell adenoma with malignant transformation: a case report.

Authors:  Masahiro Ito; Makoto Sasaki; Chun Yang Wen; Masahiro Nakashima; Toshihito Ueki; Hiromi Ishibashi; Michitami Yano; Masayoshi Kage; Masamichi Kojiro
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

5.  Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.

Authors:  Anita Iyer; Marie E Robert; Carlo B Bifulco; Ronald R Salem; Dhanpat Jain
Journal:  Hum Pathol       Date:  2008-07-07       Impact factor: 3.466

Review 6.  Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.

Authors:  Hui-Chuan Sun; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-18       Impact factor: 4.553

7.  Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.

Authors:  Juliana Passos Paschoal; Vagner Bernardo; Nathalie Henriques Silva Canedo; Osmar Damasceno Ribeiro; Adriana Caroli-Bottino; Vera Lucia Pannain
Journal:  BMC Cancer       Date:  2014-02-07       Impact factor: 4.430

8.  Human liver cancer cells and endothelial cells incorporate iodised oil.

Authors:  S Bhattacharya; A P Dhillon; M C Winslet; B R Davidson; N Shukla; S D Gupta; R Al-Mufti; K E Hobbs
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.